Đang chuẩn bị liên kết để tải về tài liệu:
Effect of dabrafenib on melanoma cell lines harbouring the BRAFV600D/R mutations
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Conventional therapeutic agents are largely unsatisfactory into the treatment of malignant melanoma. Recently, an innovative approach based on inhibitors of the mutated BRAF gene (which represents the most prevalent alteration in melanoma patients) appears very promising from the clinical point of view. |